150 related articles for article (PubMed ID: 8080293)
1. [Prognostic factors of the gastric cancer patients without distant metastasis].
Oyama S; Nakajima T; Ota K; Ishihara S; Wakabayashi K; Nishi M
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1762-7. PubMed ID: 8080293
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
3. [Important prognostic factors in surgically treated gastric cancer patients].
Hiratsuka M; Iwanaga T; Furukawa H; Yasuda T; Nakano H; Nakamori S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T
Gan To Kagaku Ryoho; 1995 Apr; 22(5):703-8. PubMed ID: 7717727
[TBL] [Abstract][Full Text] [Related]
4. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
[TBL] [Abstract][Full Text] [Related]
5. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience.
Kikuchi S; Arai Y; Morise M; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Hiki Y; Kakita A
Hepatogastroenterology; 1998; 45(22):1183-8. PubMed ID: 9756030
[TBL] [Abstract][Full Text] [Related]
9. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in gastric cancer with serosal invasion--importance of the extent of cancer infiltration in the subserosal layer].
Habu H; Kando F; Saito N; Takeshita K; Sunagawa M; Endo M
Gan No Rinsho; 1989 May; 35(6):685-9. PubMed ID: 2724547
[TBL] [Abstract][Full Text] [Related]
11. [Related factors and prognosis of hepatic metastasis and peritoneal dissemination in gastric cancer].
Wang Z; Zhan WH; He YL; Cai SR; Peng JS; Chen CQ; Ma JP; Zheng ZQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):287-90. PubMed ID: 16886104
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration.
Isozaki H; Tanaka N; Fujii K; Tanigawa N; Okajima K
Hepatogastroenterology; 2001; 48(40):1179-82. PubMed ID: 11490828
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment for advanced gastric cancer.
Maekawa S; Saku M; Maehara Y; Sadanaga N; Ikejiri K; Anai H; Kuwano H; Sugimachi K
Hepatogastroenterology; 1996; 43(7):178-86. PubMed ID: 8682459
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
[TBL] [Abstract][Full Text] [Related]
17. [Postoperative recurrence of T2 stage gastric cancer].
Yuan X; Shao Y; Cui X; Zheng C
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):499-501. PubMed ID: 11832091
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of prognostic factors in surgery of gastric cancer].
Cavallaro A; Agresta F; Rizzo S; Di Giovanni V
G Chir; 1989 Mar; 10(3):88-92. PubMed ID: 2518543
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
20. Survival predictors of patients with gastric cancer with peritoneal metastasis.
Zhu G; Zhang M; Zhang H; Gao H; Xue Y
Hepatogastroenterology; 2010; 57(101):997-1000. PubMed ID: 21033266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
